Singapore markets closed

Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
32.12-0.09 (-0.28%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,410,239
2,225,594
1,731,716
1,787,029
1,744,989
Cost of revenue
670,847
652,222
547,289
643,037
589,747
Gross profit
1,739,392
1,573,372
1,184,428
1,143,992
1,155,242
Operating expenses
Research development
65,185
62,288
52,926
50,488
50,154
Selling general and administrative
1,370,918
1,240,915
888,691
781,120
597,450
Total operating expenses
1,500,288
1,372,937
1,010,980
893,732
667,755
Operating income or loss
239,104
200,435
173,448
250,260
487,487
Interest expense
6,126
5,926
1,861
640.0297
1,134
Income before tax
350,559
317,086
206,581
309,625
567,365
Income tax expense
41,220
39,497
39,150
68,433
103,969
Income from continuing operations
309,339
277,590
167,431
241,192
463,396
Net income
291,377
259,418
174,183
247,921
464,399
Net income available to common shareholders
291,377
259,418
174,183
247,921
464,399
Basic EPS
0.56
0.65
0.43
0.62
1.16
Diluted EPS
0.56
0.65
0.43
0.62
1.16
Basic average shares
408,241
399,104
405,078
399,873
400,344
Diluted average shares
408,241
399,104
405,078
399,873
400,344